Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600135096) titled 'Clock Gene PER2-Mediated Lipid Metabolism and Senescence of Pulmonary Epithelial Cells in Interstitial Lung Disease-associated Fibrosis and Melatonin Intervention' on Oct. 23.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: The First Affiliated Hospital of the Baotou Medical College of Inner Mongolia University of Science and Technology
Condition:
Interstitial lung disease is one of the most common and clinically significant complications of connective tissue diseases, mainly manifested as pulmonary fibrosis.
Intervention:
CTD group:N/A
ILD-associated pulmonary fibrosis gro...